ArticleJournal of thoracic disease2025
Semi-quantitative software evaluation of COVID-19 CT examinations-correlation with clinical parameters.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Software-guided semi-quantitative analysis of coronavirus disease 2019 (COVID-19) pneumonia in lung computed tomography (CT) datasets for severity assessment. Further to correlate imaging findings with the need of intensive care medicine and clinical parameters. Methods: This single-center retrospective study analyzed 66 consecutive patients (31 females, mean age 64.6±16.2 years) with lung CT datasets from 12/2020 to 05/2021 and confirmed COVID-19 pneumonia. Lung CT datasets were evaluated using a semi-quantitative software for segmentation and quantification. Correlation with underlying diseases, laboratory parameters and further course were assessed, including intubation and need for intensive care. Results: Total lung volume was 3,903.65±1,185.67 mL, mean volume of opacities was 866.52±829.29 mL, reflecting 23.54%±21.92% of total lung volume. Volume of high opacities was 186.88±208.15 mL reflecting 0.06%±0.07% of total lung volume. Overall, 12 patients died (18.2%), 10 patients (15.2%) required intubation and in 27 cases (40.9%) intensive care was necessary. In patients who died volume of opacities and high opacities were significantly higher (P<0.05). Significant differences with a risk for needing intensive care medicine were extensive pulmonary opacities, volume of high opacities, and percentage of high opacities (P<0.001 each). Conclusions: COVID-19 pneumonia may be semi-quantified using an artificial intelligence (AI)-based software approach. Quantitative methods could provide precise information on the volume of opacities and may allow detecting connections to patient therapy, including the need for intensive care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.